Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 628597, 14 pages
http://dx.doi.org/10.1155/2014/628597
Review Article

To Look Beyond Vasospasm in Aneurysmal Subarachnoid Haemorrhage

1Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois, Faculty of Human Medicine and Biology, Lausanne University, rue du Bugnon 46, 1011 Lausanne, Switzerland
2Department of Intensive Care Medicine, Centre Hospitalier Universitaire Vaudois, Faculty of Human Medicine and Biology, Lausanne University, rue du Bugnon 46, 1011 Lausanne, Switzerland

Received 11 March 2014; Accepted 7 May 2014; Published 19 May 2014

Academic Editor: Aaron S. Dumont

Copyright © 2014 Giulia Cossu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. K. de Rooij, F. H. H. Linn, J. A. van der Plas, A. Algra, and G. J. E. Rinkel, “Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 12, pp. 1365–1372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Venti, “Subarachnoid and intraventricular hemorrhage,” Frontiers of Neurology and Neuroscience, vol. 30, pp. 149–153, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Hop, G. J. Rinkel, A. Algra, and J. van Gijn, “Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review,” Stroke, vol. 28, no. 3, pp. 660–664, 1997. View at Publisher · View at Google Scholar
  4. E. H. Brilstra, G. J. E. Rinkel, A. Algra, and J. Gijn, “Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage,” Neurology, vol. 55, no. 11, pp. 1656–1660, 2000. View at Google Scholar · View at Scopus
  5. B. Ljunggren, L. Brandt, and H. Saveland, “Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine,” Journal of Neurosurgery, vol. 61, no. 5, pp. 864–873, 1984. View at Google Scholar · View at Scopus
  6. N. F. Kassell, J. C. Torner, E. C. Haley Jr., J. A. Jane, H. P. Adams, and G. L. Kongable, “The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results,” Journal of Neurosurgery, vol. 73, no. 1, pp. 18–36, 1990. View at Google Scholar · View at Scopus
  7. R. L. Macdonald, “Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage,” Expert Opinion on Investigational Drugs, vol. 17, no. 11, pp. 1761–1767, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Kramer and J. Fletcher, “Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis,” Stroke, vol. 40, no. 10, pp. 3403–3406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Dankbaar, M. Rijsdijk, I. C. van der Schaaf, B. K. Velthuis, M. J. H. Wermer, and G. J. E. Rinkel, “Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage,” Neuroradiology, vol. 51, no. 12, pp. 813–819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. I. Vergouwen, D. Ilodigwe, and R. L. MacDonald, “Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects,” Stroke, vol. 42, no. 4, pp. 924–929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. B. Bederson, A. L. Levy, W. H. Ding et al., “Acute vasoconstriction after subarachnoid hemorrhage,” Neurosurgery, vol. 42, no. 2, pp. 352–362, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Kusaka, M. Ishikawa, A. Nanda, D. N. Granger, and J. H. Zhang, “Signaling pathways for early brain injury after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 8, pp. 916–925, 2004. View at Google Scholar · View at Scopus
  13. F. A. Sehba, R. M. Pluta, and J. H. Zhang, “Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury,” Molecular Neurobiology, vol. 43, no. 1, pp. 27–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. A. Simeone, K. G. Ryan, and J. R. Cotter, “Prolonged experimental cerebral vasospasm,” Journal of Neurosurgery, vol. 29, no. 4, pp. 357–366, 1968. View at Google Scholar · View at Scopus
  15. W. J. Cahill, J. H. Calvert, and J. H. Zhang, “Mechanisms of early brain injury after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 11, pp. 1341–1353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Hansen-Schwartz, P. Vajkoczy, R. L. Macdonald, R. M. Pluta, and J. H. Zhang, “Cerebral vasospasm: looking beyond vasoconstriction,” Trends in Pharmacological Sciences, vol. 28, no. 6, pp. 252–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Y. Schwartz, A. Masago, F. A. Sehba, and J. B. Bederson, “Experimental models of subarachnoid hemorrhage in the rat: a refinement of the endovascular filament model,” Journal of Neuroscience Methods, vol. 96, no. 2, pp. 161–167, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Nornes, “The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm,” Journal of Neurosurgery, vol. 39, no. 2, pp. 226–234, 1973. View at Google Scholar · View at Scopus
  19. E. W. Lang, R. R. Diehl, and H. M. Mehdorn, “Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: the phase relationship between arterial blood pressure and cerebral blood flow velocity,” Critical Care Medicine, vol. 29, no. 1, pp. 158–163, 2001. View at Google Scholar · View at Scopus
  20. A. Losiniecki and M. Zuccarello, “Subarachnoid hemorrhage: effect on cerebral blood flow and cerebral metabolism,” Frontiers in Bioscience, vol. 13, no. 5, pp. 1845–1856, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Berendes, M. Walter, P. Cullen et al., “Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage,” The Lancet, vol. 349, no. 9047, pp. 245–249, 1997. View at Publisher · View at Google Scholar
  22. E. F. M. Wijdicks, M. Vermeulen, and J. A. T. Haaf, “Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm,” Annals of Neurology, vol. 18, no. 2, pp. 211–216, 1985. View at Google Scholar · View at Scopus
  23. R. E. Harbaugh, “Aneurysmal subarachnoid hemorrhage and hyponatremia,” Contemporary Neurosurgery, vol. 15, pp. 1–5, 1993. View at Publisher · View at Google Scholar
  24. T. Meguro, C. P. R. Klett, B. Chen, A. D. Parent, and J. H. Zhang, “Role of calcium channels in oxyhemoglobin-induced apoptosis in endothelial cells,” Journal of Neurosurgery, vol. 93, no. 4, pp. 640–646, 2000. View at Google Scholar · View at Scopus
  25. W. M. van den Bergh, A. Algra, J. W. B. van der Sprenkel et al., “Hypomagnesemia after aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 52, no. 2, pp. 276–282, 2003. View at Google Scholar · View at Scopus
  26. W. M. van den Bergh, R. M. Dijkhuizen, and G. J. E. Rinkel, “Potentials of magnesium treatment in subarachnoid haemorrhage,” Magnesium Research, vol. 17, no. 4, pp. 301–313, 2004. View at Google Scholar · View at Scopus
  27. S. Fukui, H. Katoh, N. Tsuzuki et al., “Gender disparities in serum electrolytes levels after subarachnoid hemorrhage,” Journal of Clinical Neuroscience, vol. 11, no. 6, pp. 606–609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Enblad, J. Valtysson, J. Andersson et al., “Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 16, no. 4, pp. 637–644, 1996. View at Google Scholar
  29. J. Puyal, V. Ginet, and P. G. Clarke, “Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection,” Progress in Neurobiology, vol. 105, pp. 24–48, 2013. View at Publisher · View at Google Scholar
  30. J. Owens, D. J. Wyper, J. Patterson et al., “First SPET images of glutamate (NMDA) receptor activation in vivo in cerebral ischaemia,” Nuclear Medicine Communications, vol. 18, no. 2, pp. 149–158, 1997. View at Publisher · View at Google Scholar
  31. A. Germanò, M. Caffo, F. F. Angileri et al., “NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat,” Journal of Neurotrauma, vol. 24, no. 4, pp. 732–744, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Zuccarello, A. I. Lewis, S. Upputuri, J. B. Farmer, and D. K. Anderson, “Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits,” Journal of Neurotrauma, vol. 11, no. 6, pp. 691–698, 1994. View at Google Scholar · View at Scopus
  33. C. Ikonomidou and L. Turski, “Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?” The Lancet Neurology, vol. 1, no. 6, pp. 383–386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Sarrafzadeh, D. Huax, O. Sakowtz et al., “Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis,” Stroke, vol. 34, no. 6, pp. 1382–1388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Bullock, A. Zauner, J. J. Woodward et al., “Factors affecting excitatory amino acid release following severe human head injury,” Journal of Neurosurgery, vol. 89, no. 4, pp. 507–518, 1998. View at Google Scholar · View at Scopus
  36. F. A. Sehba, A. Y. Schwartz, I. Chereshnev, and J. B. Bederson, “Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 20, no. 3, pp. 604–611, 2000. View at Google Scholar · View at Scopus
  37. W. H. Ng, S. Moochhala, T. T. Yeo, P. L. Ong, and P. Y. Ng, “Nitric oxide and subarachnoid hemorrhage: elevated levels in cerebrospinal fluid and their implications,” Neurosurgery, vol. 49, no. 3, pp. 622–627, 2001. View at Google Scholar · View at Scopus
  38. H. Yatsushige, J. W. Calvert, J. Cahill, and J. H. Zhang, “Limited role of inducible nitric oxide synthase in blood-brain barrier function after experimental subarachnoid hemorrhage,” Journal of Neurotrauma, vol. 23, no. 12, pp. 1874–1882, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. M. Pluta, “Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH,” in Cerebral Vasospasm, vol. 104 of Acta Neurochirurgica Supplementum, pp. 139–147, 2008. View at Publisher · View at Google Scholar
  40. L. Hillered, P. M. Vespa, and D. A. Hovda, “Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis,” Journal of Neurotrauma, vol. 22, no. 1, pp. 3–41, 2005. View at Google Scholar · View at Scopus
  41. J. S. Beckman, T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman, “Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 4, pp. 1620–1624, 1990. View at Google Scholar · View at Scopus
  42. B. P. Thampatty, P. R. Sherwood, M. J. Gallek et al., “Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia,” Neurocritical Care, vol. 15, no. 1, pp. 19–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. R. M. Pluta, R. J. Boock, J. K. Afshar et al., “Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 87, no. 2, pp. 287–293, 1997. View at Publisher · View at Google Scholar
  44. A. Gruber, K. Roessler, A. Georgopoulos, A. Missbichler, R. Bonelli, and B. Richling, “Evaluation of big endothelin-1 concentrations in serum and ventricular cerebrospinal fluid after early surgical compared with nonsurgical management of ruptured intracranial aneurysms,” Neurosurgical Focus, vol. 8, no. 5, article e6, 2000. View at Google Scholar · View at Scopus
  45. L. Mascia, L. Fedorko, D. J. Stewart et al., “Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage,” Stroke, vol. 32, no. 5, pp. 1185–1189, 2001. View at Google Scholar · View at Scopus
  46. J. K. B. Afshar, R. M. Pluta, R. J. Boock, B. G. Thompson, and E. H. Oldfield, “Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 83, no. 1, pp. 118–122, 1995. View at Google Scholar · View at Scopus
  47. P. Gaetani, F. Marzatico, R. Rodriguez y Baena et al., “Arachidonic acid metabolism and pathophysiologic aspects of subarachnoid hemorrhage in rats,” Stroke, vol. 21, no. 2, pp. 328–332, 1990. View at Google Scholar · View at Scopus
  48. A. G. Kolias, J. Sen, and A. Belli, “Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches,” Journal of Neuroscience Research, vol. 87, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Maeda, K. Hirano, J. Nishimura, T. Sasaki, and H. Kanaide, “Endothelial dysfunction and altered bradykinin response due to oxidative stress induced by serum deprivation in the bovine cerebral artery,” European Journal of Pharmacology, vol. 491, no. 1, pp. 53–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. E. C. Haley Jr., N. F. Kassell, C. Apperson-Hansen, M. H. Maile, and W. M. Alves, “A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America,” Journal of Neurosurgery, vol. 86, no. 3, pp. 467–474, 1997. View at Publisher · View at Google Scholar
  51. J. N. Walton, “The prognosis and management of subarachnoid haemorrhage,” Canadian Medical Association journal, vol. 72, no. 3, pp. 165–175, 1955. View at Google Scholar · View at Scopus
  52. A. Spallone, M. Acqui, F. S. Pastore, and B. Guidetti, “Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage,” Surgical Neurology, vol. 27, no. 3, pp. 253–258, 1987. View at Google Scholar · View at Scopus
  53. A. S. Dumont, R. J. Dumont, M. M. Chow et al., “Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation,” Neurosurgery, vol. 53, no. 1, pp. 123–135, 2003. View at Google Scholar · View at Scopus
  54. K. N. Fountas, A. Tasiou, E. Z. Kapsalaki et al., “Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article,” Neurosurgical Focus, vol. 26, no. 5, article E22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. J. Provencio and N. Vora, “Subarachnoid hemorrhage and inflammation: bench to bedside and back,” Seminars in Neurology, vol. 25, no. 4, pp. 435–444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. R. M. Starke, N. Chalouhi, P. M. Jabbour et al., “Critical role of TNF-alpha in cerebral aneurysm formation and progression to rupture,” Journal of Neuroinflammation, vol. 11, no. 1, article 77, 2014. View at Google Scholar
  57. A. Helmy, M.-G. de Simoni, M. R. Guilfoyle, K. L. H. Carpenter, and P. J. Hutchinson, “Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury,” Progress in Neurobiology, vol. 95, no. 3, pp. 352–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Muroi, M. Hugelshofer, M. Seule et al., “Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 72, no. 3, pp. 367–375, 2013. View at Publisher · View at Google Scholar
  59. Y. Kubo, K. Ogasawara, S. Kakino et al., “Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage,” Surgical Neurology, vol. 69, no. 6, pp. 592–596, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Y. Kaynar, T. Tanriverdi, A. M. Kafadar et al., “Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 101, no. 6, pp. 1030–1036, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. R. L. Macdonald and B. K. Weir, “Cerebral vasospasm and free radicalse,” Free Radical Biology and Medicine, vol. 16, no. 5, pp. 633–643, 1994. View at Publisher · View at Google Scholar · View at Scopus
  62. H. H. Dietrich and R. G. Dacey Jr., “Molecular keys to the problems of cerebral vasospasm,” Neurosurgery, vol. 46, no. 3, pp. 517–530, 2000. View at Google Scholar · View at Scopus
  63. R. M. Pluta, “Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment,” Pharmacology & Therapeutics, vol. 105, no. 1, pp. 23–56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. J. F. Clark and F. R. Sharp, “Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 10, pp. 1223–1233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. J.-Y. Lee, R. F. Keep, Y. He, O. Sagher, Y. Hua, and G. Xi, “Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 11, pp. 1793–1803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. M. C. Loftspring, C. Hansen, and J. F. Clark, “A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system,” Medical Hypotheses, vol. 74, no. 1, pp. 63–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. P. H. Chan, “Reactive oxygen radicals in signaling and damage in the ischemic brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, no. 1, pp. 2–14, 2001. View at Google Scholar · View at Scopus
  68. P. B. L. Pun, J. Lu, and S. Moochhala, “Involvement of ROS in BBB dysfunction,” Free Radical Research, vol. 43, no. 4, pp. 348–364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. F. A. Sehba, R. Flores, A. Muller et al., “Adenosine A2A receptors in early ischemic vascular injury after subarachnoid hemorrhage: laboratory investigation,” Journal of Neurosurgery, vol. 113, no. 4, pp. 826–834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. B.-L. Sun, C.-B. Zheng, M.-F. Yang, H. Yuan, S.-M. Zhang, and L.-X. Wang, “Dynamic alterations of cerebral pial microcirculation during experimental subarachnoid hemorrhage,” Cellular and Molecular Neurobiology, vol. 29, no. 2, pp. 235–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Uhl, J. Lehmberg, H.-J. Steiger et al., “Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging,” Neurosurgery, vol. 52, no. 6, pp. 1307–1317, 2003. View at Google Scholar · View at Scopus
  72. F. A. Pennings, G. J. Bouma, and C. Ince, “Direct observation of the human cerebral microcirculation during aneurysm surgery reveals increased arteriolar contractility,” Stroke, vol. 35, no. 6, pp. 1284–1288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. F. A. Sehba, G. Mostafa, J. Knopman, V. Friedrich Jr., and J. B. Bederson, “Acute alterations in microvascular basal lamina after subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 101, no. 4, pp. 633–640, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Friedrich, R. Flores, A. Muller, and F. A. Sehba, “Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage,” Brain Research, vol. 1354, pp. 179–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Hongo, N. F. Kassel, T. Nakagomi et al., “Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery,” Journal of Neurosurgery, vol. 69, no. 2, pp. 247–253, 1988. View at Google Scholar · View at Scopus
  76. G. F. Hamann, Y. Okada, R. Fitridge, G. J. del Zoppo, and J. T. Povlishock, “Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion,” Stroke, vol. 26, no. 11, pp. 2120–2126, 1995. View at Google Scholar · View at Scopus
  77. R. Sanchez-Porras, A. Robles-Cabrera, and E. Santos, “Cortical spreading depolarization: a new pathophysiological mechanism in neurological diseases,” Medicina Clínica, vol. 142, no. 10, pp. 457–462, 2014. View at Publisher · View at Google Scholar
  78. J. P. Dreier, O. Windmüller, G. Petzold et al., “Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats,” Neurosurgery, vol. 51, no. 6, pp. 1457–1467, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. A. J. Strong, P. J. Anderson, H. R. Watts et al., “Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex,” Brain, vol. 130, part 4, pp. 995–1008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. O. W. Sakowitz, E. Santos, A. Nagel et al., “Clusters of spreading depolarizations are associated with disturbed cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage,” Stroke, vol. 44, no. 1, pp. 220–223, 2013. View at Publisher · View at Google Scholar
  81. S. E. Hopwood, M. C. Parkin, E. L. Bezzina, M. G. Boutelle, and A. J. Strong, “Transient changes in cortical glucose and lactate levels associated with peri-infarct depolarisations, studied with rapid-sampling microdialysis,” Journal of Cerebral Blood Flow and Metabolism, vol. 25, no. 3, pp. 391–401, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. B. J. Gwag, L. M. T. Canzoniero, S. L. Sensi et al., “Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons,” Neuroscience, vol. 90, no. 4, pp. 1339–1348, 1999. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Woitzik, J. P. Dreier, N. Hecht et al., “Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 2, pp. 203–212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. J. A. Hartings, J. A. Wilson, A. C. Look et al., “Full-band electrocorticography of spreading depolarizations in patients with aneurysmal subarachnoid hemorrhage,” in Cerebral Vasospasm: Neurovascular Events after Subarachnoid Hemorrhage, vol. 115 of Acta Neurochirurgica Supplement, pp. 131–141, 2013. View at Publisher · View at Google Scholar
  85. R. L. Macdonald, R. M. Pluta, and J. H. Zhang, “Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution,” Nature Clinical Practice Neurology, vol. 3, no. 5, pp. 256–263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. R. T. Cunningham, J. I. Morrow, C. F. Johnston, and K. D. Buchanan, “Serum neurone-specific enolase concentrations in patients with neurological disorders,” Clinica Chimica Acta, vol. 230, no. 2, pp. 117–124, 1994. View at Publisher · View at Google Scholar · View at Scopus
  87. G. F. Prunell, N.-A. Svendgaard, K. Alkass, and T. Mathiesen, “Delayed cell death related to acute cerebral blood flow changes following subarachnoid hemorrhage in the rat brain,” Journal of Neurosurgery, vol. 102, no. 6, pp. 1046–1054, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Cahill, J. W. Calvert, I. Solaroglu, and J. H. Zhang, “Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage,” Stroke, vol. 37, no. 7, pp. 1868–1874, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. B. R. S. Broughton, D. C. Reutens, and C. G. Sobey, “Apoptotic mechanisms after cerebral ischemia,” Stroke, vol. 40, no. 5, pp. e331–e339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. I. Gules, M. Satoh, A. Nanda, and J. H. Zhang, “Apoptosis, blood-brain barrier, and subarachnoid hemorrhage,” in Brain Edema XII, vol. 86 of Acta Neurochirurgica Supplements, pp. 483–487, 2003. View at Publisher · View at Google Scholar
  91. C. Zhou, M. Yamaguchi, G. Kusaka, C. Schonholz, A. Nanda, and J. H. Zhang, “Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 4, pp. 419–431, 2004. View at Google Scholar · View at Scopus
  92. H. Zhao, Z. Ji, D. Tang, C. Yan, W. Zhao, and C. Gao, “Role of autophagy in early brain injury after subarachnoid hemorrhage in rats,” Molecular Biology Reports, vol. 40, no. 2, pp. 819–827, 2013. View at Publisher · View at Google Scholar
  93. R. L. Macdonald, “Delayed neurological deterioration after subarachnoid haemorrhage,” Nature Reviews Neurology, vol. 10, no. 1, pp. 44–58, 2014. View at Google Scholar
  94. N. W. C. Dorsch, “A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part II: management,” Journal of Clinical Neuroscience, vol. 1, no. 2, pp. 78–92, 1994. View at Google Scholar · View at Scopus
  95. S. Fergusen and R. L. Macdonald, “Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 60, no. 4, pp. 658–667, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. R. D. Rothoerl and F. Ringel, “Molecular mechanisms of cerebral vasospasm following aneurysmal SAH,” Neurological Research, vol. 29, no. 7, pp. 636–642, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Yanagisawa, H. Kurihara, S. Kimura et al., “A novel potent vasoconstrictor peptide produced by vascular endothelial cells,” Nature, vol. 332, no. 6163, pp. 411–415, 1988. View at Google Scholar · View at Scopus
  98. R. H. Wilkins, “Cerebral vasospasm,” Critical Reviews in Neurobiology, vol. 6, no. 1, pp. 51–77, 1990. View at Google Scholar · View at Scopus
  99. C. M. Fisher, J. P. Kistler, and J. M. Davis, “Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning,” Neurosurgery, vol. 6, no. 1, pp. 1–9, 1980. View at Google Scholar · View at Scopus
  100. R. W. Crowley, R. Medel, A. S. Dumont et al., “Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage,” Stroke, vol. 42, no. 4, pp. 919–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Weidauer, H. Lanfermann, A. Raabe, F. Zanella, V. Seifert, and J. Beck, “Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA Study,” Stroke, vol. 38, no. 6, pp. 1831–1836, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. G. K. Povlsen, S. E. Johansson, C. C. Larsen, A. K. Samraj, and L. Edvinsson, “Early events triggering delayed vasoconstrictor receptor upregulation and cerebral ischemia after subarachnoid hemorrhage,” BMC Neuroscience, vol. 14, article 34, 2013. View at Publisher · View at Google Scholar
  103. O. B. Paulson, S. Strandgaard, and L. Edvinsson, “Cerebral autoregulation,” Cerebrovascular and Brain Metabolism Reviews, vol. 2, no. 2, pp. 161–192, 1990. View at Google Scholar · View at Scopus
  104. N. Dorsch, “A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture,” in Early Brain Injury or Cerebral Vasospasm, vol. 110-111 of Acta Neurochirurgica Supplements, pp. 5–6, 2011. View at Publisher · View at Google Scholar
  105. M. Jaeger, B. Jeanneret, and S. Schaeren, “Spontaneous spinal epidural haematoma during Factor Xa inhibitor treatment (Rivaroxaban),” European Spine Journal, vol. 21, supplement 4, pp. S433–S435, 2012. View at Publisher · View at Google Scholar
  106. M. Jaeger, M. U. Schuhmann, M. Soehle, C. Nagel, and J. Meixensberger, “Continuous monitoring of cerebrovascular autoregulation after subarachnoid hemorrhage by brain tissue oxygen pressure reactivity and its relation to delayed cerebral infarction,” Stroke, vol. 38, no. 3, pp. 981–986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. J. P. Dreier, S. Major, A. Manning et al., “Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage,” Brain, vol. 132, part 7, pp. 1866–1881, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. H. Hadeishi, M. Mizuno, A. Suzuki, and N. Yasui, “Hyperdynamic therapy for cerebral vasospasm,” Neurologia Medico-Chirurgica, vol. 30, no. 5, pp. 317–323, 1990. View at Google Scholar · View at Scopus
  109. S. S. Finn, S. A. Stephensen, and C. A. Miller, “Observations on the perioperative management of aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 65, no. 1, pp. 48–62, 1986. View at Google Scholar · View at Scopus
  110. A. Raabe, J. Beck, M. Keller, H. Vatter, M. Zimmermann, and V. Seifert, “Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 103, no. 6, pp. 974–981, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. E. Muench, P. Horn, C. Bauhuf et al., “Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage,” Critical Care Medicine, vol. 35, no. 8, pp. 1844–1852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. M. N. Diringer, T. P. Bleck, J. C. Hemphill III et al., “Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference,” Neurocritical Care, vol. 15, no. 2, pp. 211–240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. J. B. Bederson, E. S. Connolly Jr., H. H. Batjer et al., “Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association,” Stroke, vol. 40, no. 3, pp. 994–1025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. S. M. D. Mees, G. J. Rinkel, V. L. Feigin et al., “Calcium antagonists for aneurysmal subarachnoid haemorrhage,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD000277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. C. Muroi, J. K. Burkhardt, M. Hugelshofer, M. Seule, K. Mishima, and E. Keller, “Magnesium and the inflammatory response: potential pathophysiological implications in the management of patients with aneurysmal subarachnoid hemorrhage?” Magnesium Research, vol. 25, no. 2, pp. 64–71, 2012. View at Google Scholar
  116. R. L. MacDonald, D. J. Curry, Y. Aihara, Z.-D. Zhang, B. S. Jahromi, and R. Yassari, “Magnesium and experimental vasospasm,” Journal of Neurosurgery, vol. 100, no. 1, pp. 106–110, 2004. View at Google Scholar · View at Scopus
  117. R. S. Veyna, D. Seyfried, D. G. Burke et al., “Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 96, no. 3, pp. 510–514, 2002. View at Google Scholar · View at Scopus
  118. G. K. C. Wong, W. S. Poon, M. T. V. Chan et al., “Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial,” Stroke, vol. 41, no. 5, pp. 921–926, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. R. L. MacDonald, N. F. Kassell, S. Mayer et al., “Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial,” Stroke, vol. 39, no. 11, pp. 3015–3021, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. R. L. Macdonald, R. T. Higashida, E. Keller et al., “Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2),” The Lancet Neurology, vol. 10, no. 7, pp. 618–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. Y. Arakawa, K.-I. Kikuta, M. Hojo, Y. Goto, A. Ishii, and S. Yamagata, “Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases,” Neurosurgery, vol. 48, no. 4, pp. 723–730, 2001. View at Google Scholar · View at Scopus
  122. N. K. Chanani, D. B. Cowan, K. Takeuchi et al., “Differential effects of amrinone and milrinone upon myocardial inflammatory signaling,” Circulation, vol. 106, no. 12, supplement 1, pp. I284–I289, 2002. View at Google Scholar · View at Scopus
  123. D. Ding, R. M. Starke, A. S. Dumont et al., “Therapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage,” BioMed Research International, vol. 2014, Article ID 727428, 9 pages, 2014. View at Publisher · View at Google Scholar
  124. C.-L. Lin, H.-C. Shih, A. S. Dumont et al., “The effect of 17β-estradiol in attenuating experimental subarachnoid hemorrhage-induced cerebral vasospasm,” Journal of Neurosurgery, vol. 104, no. 2, pp. 298–304, 2006. View at Google Scholar · View at Scopus
  125. S. Srivastava, M. N. Weitzmann, S. Cenci, F. P. Ross, S. Adler, and R. Pacifici, “Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD,” Journal of Clinical Investigation, vol. 104, no. 4, pp. 503–513, 1999. View at Google Scholar · View at Scopus
  126. R. M. Pluta, A. Dejam, G. Grimes, M. T. Gladwin, and E. H. Oldfield, “Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage,” Journal of the American Medical Association, vol. 293, no. 12, pp. 1477–1484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. A. Hino, Y. Tokuyama, B. Weir et al., “Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys,” Neurosurgery, vol. 39, no. 3, pp. 562–568, 1996. View at Google Scholar
  128. P. Gaetani, F. Marzatico, B. Renault et al., “High-dose methylprednisolone and “ex vivo” release of eicosanoids after experimental subarachnoid haemorrhage,” Neurological Research, vol. 12, no. 2, pp. 111–116, 1990. View at Google Scholar · View at Scopus
  129. P. Gomis, J. P. Graftieaux, R. Sercombe, D. Hettler, B. Scherpereel, and P. Rousseaux, “Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 112, no. 3, pp. 681–688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Zhang, L. Wang, M. Liu, and B. Wu, “Tirilazad for aneurysmal subarachnoid haemorrhage,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD006778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  131. A. Munakata, H. Ohkuma, T. Nakano, N. Shimamura, K. Asano, and M. Naraoka, “Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 64, no. 3, pp. 423–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  132. X. S. Zhang, X. Zhang, M. L. Zhou et al., “Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage,” Journal of Neurosurgery, 2014. View at Publisher · View at Google Scholar
  133. T. Y. Lin, C. W. Lu, and S. J. Wang, “Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca2+ entry and mitogen-activated protein kinase signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 58, no. 14, pp. 8271–8278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. S.-J. Lee, S.-K. Bai, K.-S. Lee et al., “Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation,” Molecules and Cells, vol. 16, no. 1, pp. 97–105, 2003. View at Google Scholar · View at Scopus
  135. S. K. Khan, T. Malinski, R. P. Mason et al., “Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model,” Thrombosis Research, vol. 126, no. 4, pp. 299–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. R. G. Fassett and J. S. Coombes, “Astaxanthin, oxidative stress, inflammation and cardiovascular disease,” Future Cardiology, vol. 5, no. 4, pp. 333–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. C. Muroi, M. Hugelshofer, M. Seule, and E. Keller, “The impact of nonsteroidal anti-inflammatory drugs on inflammatory response after aneurysmal subarachnoid hemorrhage,” Neurocritical Care, vol. 20, no. 2, pp. 240–246, 2014. View at Publisher · View at Google Scholar
  138. S. Juvela, “Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 82, no. 6, pp. 945–952, 1995. View at Google Scholar · View at Scopus
  139. H. Iso, C. H. Hennekens, M. J. Stampfer et al., “Prospective study of aspirin use and risk of stroke in women,” Stroke, vol. 30, no. 9, pp. 1764–1771, 1999. View at Google Scholar · View at Scopus
  140. C. Muroi, M. Fujioka, K. Mishima et al., “Effect of ADAMTS-13 on cerebrovascular microthrombosis and neuronal injury after experimental subarachnoid hemorrhage,” Journal of Thrombosis and Haemostasis, vol. 12, no. 4, pp. 505–514, 2014. View at Publisher · View at Google Scholar
  141. U. Laufs, V. L. Fata, and J. K. Liao, “Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase,” The Journal of Biological Chemistry, vol. 272, no. 50, pp. 31725–31729, 1997. View at Google Scholar
  142. G. O'Driscoll, D. Green, and R. R. Taylor, “Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month,” Circulation, vol. 95, no. 5, pp. 1126–1131, 1997. View at Publisher · View at Google Scholar
  143. F. A. Sehba, V. Friedrich Jr., G. Makonnen, and J. B. Bederson, “Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor,” Journal of Neurosurgery, vol. 106, no. 2, pp. 321–329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. M.-Y. Tseng, M. Czosnyka, H. Richards, J. D. Pickard, and P. J. Kirkpatrick, “Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial,” Stroke, vol. 36, no. 8, pp. 1627–1632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. M.-Y. Tseng, P. J. Hutchinson, M. Czosnyka, H. Richards, J. D. Pickard, and P. J. Kirkpatrick, “Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage,” Stroke, vol. 38, no. 5, pp. 1545–1550, 2007. View at Publisher · View at Google Scholar · View at Scopus
  146. J. H. Tapia-Pérez, M. Sanchez-Aguilar, and T. Schneider, “The role of statins in neurosurgery,” Neurosurgical Review, vol. 33, no. 3, pp. 259–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. A. H. Kramer and J. J. Fletcher, “Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis,” Neurocritical Care, vol. 12, no. 2, pp. 285–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. C. P. Nolan and R. L. Macdonald, “Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm?” Neurosurgical Focus, vol. 21, no. 3, article E1, 2006. View at Google Scholar · View at Scopus
  149. A. Ecker and P. A. Riemenschneider, “Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms,” Journal of Neurosurgery, vol. 8, no. 6, pp. 660–667, 1951. View at Google Scholar · View at Scopus
  150. A. Alaraj, F. T. Charbel, and S. Amin-Hanjani, “Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage,” Neurological Research, vol. 31, no. 6, pp. 651–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. D. S. Liebeskind, “Collateral circulation,” Stroke, vol. 34, no. 9, pp. 2279–2284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  152. A. M. Naidech, J. Drescher, P. Tamul, A. Shaibani, H. H. Batjer, and M. J. Alberts, “Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 12, pp. 1340–1344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  153. S. Suzuki, M. Kimura, M. Souma, H. Ohkima, T. Iwabuchi, and T. Shimiz u, “Cerebral microthrombosis in symptomatic cerebral vasospasm—a quantitative histological study in autopsy cases,” Neurologia Medico-Chirurgica, vol. 30, no. 5, pp. 309–316, 1990. View at Google Scholar · View at Scopus
  154. R. Nau, S. Haase, S. Bunkowski, and W. Brück, “Neuronal apoptosis in the denate gyrus in humans with subarachnoid hemorrage and cerebral hypoxia,” Brain Pathology, vol. 12, no. 3, pp. 329–336, 2002. View at Google Scholar · View at Scopus
  155. M. N. Diringer, D. S. Heffez, L. Monsein, J. R. Kirsch, D. F. Hanley, and R. J. Traystman, “Cerebrovascular CO2 reactivity during delayed vasospasm in a canine model of subarachnoid hemorrhage,” Stroke, vol. 22, no. 3, pp. 367–372, 1991. View at Google Scholar · View at Scopus
  156. L. Z. Leng, M. E. Fink, and C. Iadecola, “Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage,” Archives of Neurology, vol. 68, no. 1, pp. 31–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Messerer, R. T. Daniel, and M. Oddo, “Neuromonitoring after major neurosurgical procedures,” Minerva Anestesiologica, vol. 78, no. 7, pp. 810–822, 2012. View at Google Scholar
  158. M. M. Tisdall and M. Smith, “Cerebral microdialysis: research technique or clinical tool,” British Journal of Anaesthesia, vol. 97, no. 1, pp. 18–25, 2006. View at Publisher · View at Google Scholar · View at Scopus